None listed
Conditions
Brief summary
This project aims to assess the impact of rotavirus vaccine introduction on severe gastroenteritis in South Australian children. Prevalence of rotavirus coded hospitalisations and all-cause gastrenteritis hospitalisations will be compared for a two year period prior to introduction of the vaccine and a two year period following introduction of the vaccine. Severity of rotavirus coded admissions during the periods will also be assessed.
Interventions
introduction of rotavirus vaccine onto the National Immunisation Program in Australia. Rotavirus vaccine (Rotateq in SA) was introduced to be administered at 2,4 and 6 months of for infants born in Australia from 01May2011. This study is observational and examined the changes in severe rotavirus and severe gastroenteritis disease before and after the introduction of the vaccine. The study period is 01May2005 - 30April2011. Information regarding severe gastroneteritis was obtained from health
introduction of rotavirus vaccine onto the National Immunisation Program in Australia. Rotavirus vaccine (Rotateq in SA) was introduced to be administered at 2,4 and 6 months of for infants born in Australia from 01May2011. This study is observational and examined the changes in severe rotavirus and severe gastroenteritis disease before and after the introduction of the vaccine. The study period is 01May2005 - 30April2011. Information regarding severe gastroneteritis was obtained from health information portal statistics and review of medical admission case notes for children born pre and post introduction of the rotavirus vaccine onto the National Immunisation Program.
Sponsors
Children, Youth and Women's health Service
Eligibility
Sex/Gender
All
Age
0 to 6 Years
Healthy volunteers
No
Inclusion criteria
aged 0-less than 6 years of age admitted to hospital with ICD10-AM separation codes consistent with rotaviral infection or gastroenteritis of any cause.
Exclusion criteria
nosocomial irotaviral nfections (defined as onset >48 hours post admission date) will be reported separately in the severity analysis
Outcome results
None listed